Academic Research in LA

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Academic Research in LA"

Transcription

1 Academic Research in LA Dr. Carlos H. Barrios Faculdade de Medicina, PUCRS Instituto do Câncer, HMD LACOG, Latin American Cooperative Oncology Group Porto Alegre, Brasil

2

3 36% improvement

4 Age-Adjusted Male Mortality Siegel R, et al. CA Cancer J Clin 2011;61: VC 2011 American Cancer Society.

5 Age-Adjusted Female Mortality Siegel R, et al. CA Cancer J Clin 2011;61: VC 2011 American Cancer Society.

6 Age adujsted mortality rates, women. Brazil ( ) Source, INCA, MS, Brazil

7 Number of Studies (N= ) ClinicalTrials.gov currently lists studies in 181 countries Researched on Feb 2 nd

8 Number of Studies (N= ) ClinicalTrials.gov currently lists studies in 181 countries Non-US Only (45%) US Only (40%) Not Specified* (9%) Both US/Non-US (6%) Total 160,326 Researched on Feb 2 nd

9 Clinical Research in South America World South America 5474 (3.4%) Argentina 1689 Bolivia 24 Brazil 3708 (2.3%) Chile 904 Colombia 724 Ecuador 84 Guyana 1 Paraguay 15 Peru 688 Suriname 1 Uruguay 48 Venezuela 137 (Feb, 2014)

10 Number of Studies in Cancer (N=41.757) Researched on Feb 2 nd

11 Clinical Cancer Research in South America World South America (2.4%) Argentina 452 Brazil 711 (1.7%) Chile 213 Colombia 146 Ecuador 19 Peru 231 Uruguay 20 Venezuela 38 (Feb, 2014)

12 Clinical Cancer Research Europe World (Feb, 2014)

13 Early vs. Late Phase Trials in Emerging Regions Asia 102 6% Latin America 22 4% 35 6% % % % 52 3% % 26 6% 61 14% % 16 3% % 1% 41 22% % 18 4% % Middle East % 6 3% Africa clinicaltrials.gov

14 CLINICAL RESEARCH REGULATORY TIMELINES ACROSS THE WORLD 5-12 months CANADA 3-4 months 5 months REINO UNIDO SUÉCIA 3 months 4-5 month s UNITES STATES 3 months FRANÇA 12 months MÉXICO 3 4 months COLOMBIA PERU 4 5 months BRAZIL months 3 months 4 months AUSTRÁLIA CHILE ARGENTINA 4 4,5 months 9 months 4 months Adapted from: Hurley D. GCP Journal March st Annual Drug Information Association Meeting, 2005.

15 REGULATORY AGENCIES APPROVAL TIMES in the ALTTO trial (BIG02-06) Average* 58d 26d 60d 171d TIME TO APPROVAL IN DAYS P=.046 P=.21 P=.05 In this study the regulatory agencies in South America required many more days to approve the protocol in comparison to remaining regions EUROPE NORTH AMERICA ASIA-PACIFIC SOUTH AMERICA AFRICA PARTICIPATING COUNTRIES ANOVA F = 3.39, P = 0.031

16 Nature, Vol 450, November 29 th, 2007

17 Nature, Vol 450, November 29 th, 2007 US$28 billion investment in S&T 1.5% of GDP (increase of 50%)

18 US$28 billion investment in S&T 1.5% of GDP (increase of 50%) Lack of technological innovation in the private industry. Most researchers in the public sector. Nature, Vol 450, November 29 th, 2007

19 US$28 billion investment in S&T 1.5% of GDP (increase of 50%) Lack of technological innovation in the private industry. Most researchers in the public sector. 2% of scientific publications Ranking 15 th in the world Nature, Vol 450, November 29 th, 2007

20 US$28 billion investment in S&T 1.5% of GDP (increase of 50%) Lack of technological innovation in the private industry. Most researchers in the public sector. 2% of scientific publications Ranking 15 th in the world 0.1% of global registered patents Nature, Vol 450, November 29 th, 2007

21 Nature, Vol 450, November 29 th, 2007

22 Brazil Research and Development Expenditure (% of GDP) Brazil 2010: 1.1% Nature, Vol 450, November 29 th, 2007

23 In 2011, R&D expenditure was 0 65% of GDP, which is many times less than in developed countries

24

25

26 Saturation of Clinical Trial Sites Region Number of Trial Sites (per 1M Population) US 82 Western Europe 11 Central / Eastern Europe 8 Latin America 2 Asia Pacific < 1 Source: Raps Focus, 2009, Latin American CTAs

27 Private Participation in R&D is Relatively Low in LA (% of R&D financed by the private sector) Sources: RICYT (Red de Indicadores de Ciencias y Tecnologia, 2007 OEDC Data, 2008

28 Where are the Researchers? Private Sector Government University Brazil, Ministry of Science and Technology Main Science and Technology Indicators OECD, 2007

29 Industry-University Collaboration in LA (relatively low as compared with other countries) Weighted Average: Rating is from 1-7 (7 means highest collaboration) World Economic Forum: Global Competitiveness Report

30 Comparative Patenting by LA Countries (Cumulative ) US Patent Office Data,

31 Scientific Publications by Researchers from Brazilian Institutions ( ) Thomson Reuters (Scientific) Inc. Web of Science (Science Citation Index Expanded), May 2010.

32 Brazilian Science in Latin America Source: Thomson Reuters. National Science IndicatorsBrazilian Ministry of Science and Technology, 18 Sep Source: Thomson Reuters. National Science Indicators Brazilian Ministry of Science and Technology, 18 Sep

33 The Geography of Clinical Cancer Research. Analysis of ASCO Abstracts Saad ED, et al. Annals of Oncology 21:627, 2010

34 The Geography of Clinical Cancer Research. Analysis of ASCO Abstracts There was a statistically significant temporal trend in the proportion of multinational studies. Multinational studies and abstracts with United States nationality were more frequently presented in oral and poster fashion and had more frequent involvement of the pharmaceutical industry. Saad ED, et al. Annals of Oncology 21:627, 2010

35 Clinical Research in LA: Challenges Regulatory Processes; Bureaucracy. Lack of Investment (Public and Private). Sponsor is responsible for 100% of costs (need to cover standard procedures). Post-study medication provision. Restrictions in sending biological material across borders for genetic testing. Human Resources: Training and support of young talents. Public Education (general population) with regard to Clinical Research. Need to develop and support a Culture of Cooperation.

36

37 Potential of Accrual members 57 sites 12 countries LACOG Institutions Number of new cases per month = Breast Prostate Colorrectal: Lung Skin Stomach Cervix Head and Neck Uterus 204 LNH Sarcoma Melanoma Larynx Brain Thyroid 213 Kidney Esophagus Pancreas Leukemia Hepatic LH Mieloma

38

Oncology Clinical Trials in Emerging Regions A Trend Analysis

Oncology Clinical Trials in Emerging Regions A Trend Analysis Oncology Clinical Trials in Emerging Regions A Trend Analysis W H I T E P A P E R Toll Free Number: 1-888-987-2691 1 Cancer represents considerable unmet medical need and has been leading cause of death

More information

Regional Update Pandemic (H1N1) 2009

Regional Update Pandemic (H1N1) 2009 Regional Update Pandemic (H1N1) 2009 (September 18, 2009-22 h GMT; 17 h EST) Update on the Qualitative Indicators For Epidemiological Week 36 (EW 36), from 6 September to 12 September, 17 countries reported

More information

Genetic Disorders and Congenital Defects in Latin America and the Caribbean

Genetic Disorders and Congenital Defects in Latin America and the Caribbean Genetic Disorders and Congenital Defects in Latin America and the Caribbean Victor B. Penchaszadeh, MD, MSPH Columbia University, New York and Pan American Health Organization CAPABILITY Workshop Lund,

More information

Cancer prevalence. Chapter 7

Cancer prevalence. Chapter 7 Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.

More information

ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH

ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH Michal Krzyzanowski WHO ECEH Bonn Office 1 Exposure - Response Population X Exposure IMPACT ESTIMATE FOR POPULATION X Population X health status WHO Air

More information

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American / World Outline Facts and Figures Suicide a major Public problem Suicide in the Americas Risk and Protective factors and related interventions

More information

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST) Regional Update Pandemic (H1N1) 29 (July 6, 21-17 h GMT; 12 h EST) The information contained within this update is obtained from data provided by Ministries of Health of Member States and National Influenza

More information

Extension for Community Healthcare Outcomes. Project ECHO Ellen Baker, MD, MPH UT MD Anderson Cancer Center

Extension for Community Healthcare Outcomes. Project ECHO Ellen Baker, MD, MPH UT MD Anderson Cancer Center Extension for Community Healthcare Outcomes Project ECHO Ellen Baker, MD, MPH UT MD Anderson Cancer Center No financial relationships to disclose In the U.S. and around the world, people are not getting

More information

BRAZIL : what s new in the Regulations for Nutrition? Ary Bucione Danisco / DuPont

BRAZIL : what s new in the Regulations for Nutrition? Ary Bucione Danisco / DuPont BRAZIL : what s new in the Regulations for Nutrition? Ary Bucione Danisco / DuPont 1 Agenda Agenda Introduction with South America South America - Health status Brazil: Mortality status Regulatory Min.

More information

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( ) Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications

More information

FEASIBILITY ASSESSMENT: CORNERSTONE OF SUCCESSFUL CLINICAL TRIAL PLANNING

FEASIBILITY ASSESSMENT: CORNERSTONE OF SUCCESSFUL CLINICAL TRIAL PLANNING FEASIBILITY ASSESSMENT: CORNERSTONE OF SUCCESSFUL CLINICAL TRIAL PLANNING VERONIKA FEKETE, MD MANAGER FEASIBILITY RESEARCH AND PATIENT RECRUITMENT SERVICES, PSI CRO 1 WHAT CAN GO WRONG WITH A CLINICAL

More information

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages 2017 highlights Hepatitis B and C in the Spotlight: A public health response in the Americas Key Messages Regarding the national structures developed to support the response to the viral hepatitis epidemics,

More information

Project RAS6/063. IAEA activities in Nuclear Medicine and Nuclear Cardiology. Maurizio Dondi Head, Nuclear Medicine Section

Project RAS6/063. IAEA activities in Nuclear Medicine and Nuclear Cardiology. Maurizio Dondi Head, Nuclear Medicine Section Project RAS6/063 Strengthening the Application of Nuclear Medicine in the Management of Cardiovascular Diseases Regional Training Course on Imaging in ischemic heart disease and cardiac failure activities

More information

Seizures of ATS (excluding ecstasy ), 2010

Seizures of ATS (excluding ecstasy ), 2010 Seizures of ATS (excluding ecstasy ), 2010 (countries and territories reporting seizures* of more than 10 kg) 9 5.1 8.7 12.9 Ghana Armenia 0.7 9.9 1 2.1 Syrian Arab Republic Korea (Republic of) Iraq Islamic

More information

Estimating the global burden of tuberculosis. WHO estimates of TB incidence, prevalence and mortality, by country,

Estimating the global burden of tuberculosis. WHO estimates of TB incidence, prevalence and mortality, by country, Estimating the global burden of tuberculosis WHO estimates of TB incidence, prevalence and mortality, by country, 1990 2007 This morning s presentation Why estimate the burden? A brief history of TB estimates

More information

Investigating Disease Epidemics through Simulation with a focus on Chikungunya in the Americas

Investigating Disease Epidemics through Simulation with a focus on Chikungunya in the Americas Investigating Disease Epidemics through Simulation with a focus on Chikungunya in the Americas Alexandra L. Stone and Jean C. Galan-Rivera Mentors: Dr. Jacob Oleson and Dr. Grant Brown ISIB 2015 University

More information

Human Papillomavirus and Related Cancers

Human Papillomavirus and Related Cancers Human Papillomavirus and Related Cancers Summary Report Update. September 15, 2010. AMERICAS - ii - Rights c WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) 2010 All rights

More information

The Global Cancer Epidemic. Tim Byers MD MPH Colorado School of Public Health

The Global Cancer Epidemic. Tim Byers MD MPH Colorado School of Public Health The Global Cancer Epidemic Tim Byers MD MPH Colorado School of Public Health This year there will be more deaths in the World from cancer than from: Combined This year there will be more deaths in the

More information

Current Status in Latin America

Current Status in Latin America WHO International Consultation 15 to 17 October 2014 Munich, Germany JUSTIFICATION OF THE USE OF CT FOR INDIVIDUAL HEALTH ASSESSMENT OF ASYMPTOMATIC PEOPLE Current Status in Latin America Gloria Soto Giordani

More information

Influenza Vaccine Use In the Americas

Influenza Vaccine Use In the Americas Influenza Vaccine Use In the Americas Network for Evaluation of Influenza Vaccine Effectiveness REVELAC-i Alba Maria Ropero-Alvarez Comprehensive Family Immunization Unit PAHO/FGL/IM Global Vaccine and

More information

Overview. Retinal vascularisation during development. Classification of ROP. Visual loss from retinopathy of prematurity: first global estimates

Overview. Retinal vascularisation during development. Classification of ROP. Visual loss from retinopathy of prematurity: first global estimates Visual loss from retinopathy of prematurity: first global estimates Overview ROP - the condition, risk factors and control ROP as a cause of visual loss Earlier estimates New global estimates MARCH seminar,

More information

Key Issue #1: Why Does Development Vary Among Countries? (299)

Key Issue #1: Why Does Development Vary Among Countries? (299) AP Human Geography Mr. Horas Chapter 9: Development (Pages 296 329) Economic Development Before You Read: If you had to develop a scale to measure how developed (advanced ) a country is, what are three

More information

Part 3. Global pharmacy workforce description

Part 3. Global pharmacy workforce description Part 3. Global pharmacy workforce description Author Tana Wuliji, FIP Project Manager Human resources and education Summary The 2009 FIP Global Pharmacy Workforce Survey (English, French, Spanish) and

More information

CANCER FACT SHEETS: STOMACH CANCER

CANCER FACT SHEETS: STOMACH CANCER CANCER FACT SHEETS: STOMACH CANCER Estimated age-standardised rates (World) in the world (per 100 000) At a glance WHO Western Pacific Region China Less developed regions World More developed regions IARC

More information

GLOBAL HIV STATISTICS

GLOBAL HIV STATISTICS F A C T S H E E T W O R L D A I D S D A Y 2017 GLOBAL HIV STATISTICS 20.9 million people were accessing antiretroviral therapy in June 2017. 36.7 million [30.8 million 42.9 million] people globally were

More information

GLOBAL OUTLOOK ECONOMIC WATCH. March 2018

GLOBAL OUTLOOK ECONOMIC WATCH. March 2018 GLOBAL OUTLOOK ECONOMIC WATCH March 20 Global Outlook March 20 Strong global momentum continues in 1Q driven by trade, despite some weaker data in DM at the beginning of the year World GDP growth in 1Q

More information

Case Study - Turma Do Bem- Dentista do Bem

Case Study - Turma Do Bem- Dentista do Bem Fabio Bibancos Executive Director Rua Sousa Ramos, 311 Vila Mariana, São Paulo- SP 55-11-5084-7276 Introduction Case Study - Turma Do Bem- Dentista do Bem This case study describes the services provided

More information

Translating Science to end HIV in Latin America and the Caribbean

Translating Science to end HIV in Latin America and the Caribbean Translating Science to end HIV in Latin America and the Caribbean Mexico City, Mexico, 17 th - 18 th and 21 st April www.iasociety.org IAS 2017 post-conference workshop, 17 April 2018 Challenges for PrEP

More information

Data, open data and big data: challenges and opportunities

Data, open data and big data: challenges and opportunities Data, open data and big data: challenges and opportunities Wouter Schallier Chief, Hernán Santa Cruz Library A big thank you to: Claudia Vilches & Gabriela Andaur Content 1. Are we ready for BIG data?

More information

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009. B. UPDATE ON THE PANDEMIC (H1N1) 2009 CD50/INF/6 (Eng.) - 7 - Annex B Background 20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus

More information

Annex 2 A. Regional profile: West Africa

Annex 2 A. Regional profile: West Africa Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262

More information

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List

More information

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

Developing & Commercializing Targeted Small Molecule Drugs in Cancer Developing & Commercializing Targeted Small Molecule Drugs in Cancer SAFE HARBOR STATEMENT 2 Forward-looking statements made in the course of this presentation are made pursuant to the safe harbor provisions

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2017 334 Jefferson Avenue, Scranton,

More information

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures

More information

Turma Do Bem: Dentista do Bem Fabio Bibancos

Turma Do Bem: Dentista do Bem Fabio Bibancos Turma Do Bem: Dentista do Bem Fabio Bibancos This case study is part of the CHMI case study series. CENTER FOR HEALTH MARKET INNOVATIONS (CHMI) CHMI identifies, analyzes and connects programs working to

More information

In- Vitro Fertilization (IVF) - Global Market Outlook ( )

In- Vitro Fertilization (IVF) - Global Market Outlook ( ) Report Information More information from: https://www.wiseguyreports.com/reports/456551-in-vitro-fertilization-ivf-global-market-outlook In- Vitro Fertilization (IVF) - Global Market Outlook (2015-2022)

More information

International Operations overview and strategy. Maziar Mike Doustdar EVP International Operations. Slide 1

International Operations overview and strategy. Maziar Mike Doustdar EVP International Operations. Slide 1 Slide 1 International Operations overview and strategy Maziar Mike Doustdar EVP International Operations KUALA LUMPUR Home of International Operations Business Area Southeast Asia Slide 2 Forward-looking

More information

Global E-Cigarette & Vaporizer Market Research Report - Forecast to 2027

Global E-Cigarette & Vaporizer Market Research Report - Forecast to 2027 Report Information More information from: https://www.marketresearchfuture.com/reports/788 Global E-Cigarette & Vaporizer Market Research Report - Forecast to 2027 Report / Search Code: MRFR/CR/0304-CRR

More information

MONITORING COMPASSIONATE USE OF NEW DRUGS FOR TUBERCULOSIS

MONITORING COMPASSIONATE USE OF NEW DRUGS FOR TUBERCULOSIS MONITORING COMPASSIONATE USE OF NEW DRUGS FOR TUBERCULOSIS MONITORING COMPASSIONATE USE OF NEW DRUGS FOR TUBERCULOSIS Compassionate Use (CU) programs have been utilized for new cancer and HIV drugs to

More information

What can be done against XDR-TB?

What can be done against XDR-TB? What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =

More information

World Health Day 2013 Remarks of PAHO Director Carissa F. Etienne

World Health Day 2013 Remarks of PAHO Director Carissa F. Etienne World Health Day 2013 Remarks of PAHO Director Carissa F. Etienne Hon. Ambassadors, Mr. Bill Corr, Deputy Secretary, U.S. Dept. of Health and Human Services, Distinguished Speakers, Executive Management

More information

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority HIBA ABDALRAHIM Capsca Focal Point Public Health Authority Introduction Definition Symptom Transmission Global situation Local situation Control Content Introduction Yellow fever (YF) is a mosquito-borne

More information

The Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration

The Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration The Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration 2012.10.23 (TUE) North-East Asia Forum on Trade and Transport Facilitation 1 CONTENTS 1. Significance of Trilateral

More information

The Propylene Value Chain

The Propylene Value Chain The Propylene Value Chain An examination of factors influencing the propylene downstream chain George Martin Senior Consultant 2016 Annual APLA Reunion 19-22 November 2016 Sheraton Hotel Buenos Aires 1

More information

Recipients of development assistance for health

Recipients of development assistance for health Chapter 2 Recipients of development assistance for health Both low- and middle-income countries are eligible for development assistance for health (DAH). In addition to income, burden of disease, which

More information

GSK VACCINES: KEY GROWTH DRIVERS

GSK VACCINES: KEY GROWTH DRIVERS GSK VACCINES: KEY GROWTH DRIVERS Martin Andrews Senior Vice President, Global Vaccines Centre of Excellence, GSK Biologicals Millions of children die from infectious diseases Many of these deaths are preventable

More information

NATURAL NATU CYCLES RAL

NATURAL NATU CYCLES RAL NATURAL CYCLES in low resource countries Has it a place? Nebojsa RADUNOVIC University of Belgrade - Institute for Obstetrics and Gynaecology ESHRE Campus From natural cycle to minimal stimulation Maribor

More information

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004 MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer

More information

Global Radiation Therapy Market Report

Global Radiation Therapy Market Report Global Radiation Therapy Market Report ----------------------------------------- 2013 Executive Summary Radiotherapy is used to kill cancerous cells and is commonly used either alone or in combination

More information

SMOKING AND CANCER RISK

SMOKING AND CANCER RISK SMOKING AND CANCER RISK The effects of smoking on health were documented in a landmark report by the Surgeon General in 1964. Since then the devastating effect from smoking on millions of American lives

More information

Gisele Almeida Public Policies, Regulation, and Health Financing Health Systems and Services

Gisele Almeida Public Policies, Regulation, and Health Financing Health Systems and Services Gisele Almeida Public Policies, Regulation, and Health Financing Health Systems and Services Challenges to the Health Sector External Context Complexity of health determinants Multiplicity of initiatives

More information

Samuel M. Lesko, MD, MPH Director of Research/Medical Director

Samuel M. Lesko, MD, MPH Director of Research/Medical Director Cancer in Northeastern Pennsylvania: Incidence, Mortality and Survival for Common Cancers Samuel M. Lesko, MD, MPH Director of Research/Medical Director May 11 334 Jefferson Avenue, Scranton, PA 1851-57-941-7984

More information

Highlights on PVC Stabilization for Pipes Comparison and Trends April 2015 Dr. Alexander Schmid

Highlights on PVC Stabilization for Pipes Comparison and Trends April 2015 Dr. Alexander Schmid Highlights on PVC Stabilization for Pipes Comparison and Trends 13 14 April 2015 Dr. Alexander Schmid Agenda Overview PVC pipes, stabilizers and markets Worldwide trends for PVC pipes Comparison of Pb,

More information

Continuous Renal Replacement Therapy (CRRT) - Global Market Outlook ( )

Continuous Renal Replacement Therapy (CRRT) - Global Market Outlook ( ) Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Continuous Renal Replacement Therapy (CRRT) - Global Market Outlook (2015-2022) Continuous Renal Replacement Therapy

More information

A Summary of Childhood Cancer Statistics in Australia,

A Summary of Childhood Cancer Statistics in Australia, What is the Australian Paediatric Cancer Registry (APCR)? The APCR is one of only a few national registries of childhood cancer in the world. It covers all Australian children aged 0-14 years old at diagnosis.

More information

March of Dimes Global Programs. First Capability Workshop Trolleholm, Sweden 8 May 2007

March of Dimes Global Programs. First Capability Workshop Trolleholm, Sweden 8 May 2007 March of Dimes Global Programs First Capability Workshop Trolleholm, Sweden 8 May 2007 What My Presentation Will Cover Description of the March of Dimes Description of its Global Programs Initial activities

More information

Human Papillomavirus and Related Diseases Report BRAZIL

Human Papillomavirus and Related Diseases Report BRAZIL Human Papillomavirus and Related Diseases Report BRAZIL Version posted at www.hpvcentre.net on 27 July 2017 - ii - Copyright and Permissions ICO Information Centre on HPV and Cancer (HPV Information Centre)

More information

Chikungunya: Perspectives and Trends Global and in the Americas. Presenter: Dr. Eldonna Boisson PAHO/WHO

Chikungunya: Perspectives and Trends Global and in the Americas. Presenter: Dr. Eldonna Boisson PAHO/WHO Chikungunya: Perspectives and Trends Global and in the Americas Presenter: Dr. Eldonna Boisson PAHO/WHO Outline What is chikungunya Where did chikungunya start? Chikungunya spread - Africa, Asia, Europe,

More information

HPV Vaccines: Background and Current Status

HPV Vaccines: Background and Current Status HPV Vaccines: Background and Current Status Bogota, Colombia, 2007 Jon Kim Andrus, MD HPV and Cervical Cancer Evidence that HPV is essential: Documented molecular studies of cervical cancer Case-control

More information

AN EMPIRICAL EVALUATION OF PERIOD SURVIVAL ANALYSIS USING DATA FROM THE CANADIAN CANCER REGISTRY. Larry F. Ellison MSc, Statistics Canada

AN EMPIRICAL EVALUATION OF PERIOD SURVIVAL ANALYSIS USING DATA FROM THE CANADIAN CANCER REGISTRY. Larry F. Ellison MSc, Statistics Canada AN EMPIRICAL EVALUATION OF PERIOD SURVIVAL ANALYSIS USING DATA FROM THE CANADIAN CANCER REGISTRY Larry F. Ellison MSc, Statistics Canada Introduction Long-term survival rates are important outcome measures

More information

La#n America: Regulatory trends across the region

La#n America: Regulatory trends across the region IADSA Annual mee,ng, April 2013, Jakarta, Indonesia La#n America: Regulatory trends across the region Ta#ana Pires, Ph.D. President, ALANUR La,n America Alliance for Responsible Nutri,on Director of ABIAD

More information

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020 BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...

More information

Human Papillomavirus and Related Diseases Report AMERICAS

Human Papillomavirus and Related Diseases Report AMERICAS Human Papillomavirus and Related Diseases Report AMERICAS Version posted at www.hpvcentre.net on 27 July 2017 - ii - Copyright and Permissions ICO Information Centre on HPV and Cancer (HPV Information

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2201/15 27

More information

Preventing & Treating Cervical Cancer in Low-Resource Settings. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology

Preventing & Treating Cervical Cancer in Low-Resource Settings. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Preventing & Treating Cervical Cancer in Low-Resource Settings Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer is Preventable Known Etiology: Human Papillomavirus

More information

Histiocytosis in Argentina Since 1991

Histiocytosis in Argentina Since 1991 Histiocytosis in Argentina Since 1991 AIM To present the experience of a multidisciplinary study group focused on rare and complex histiocytic disorders. Langerhans Cell Histiocytosis (LCH) Disregulation

More information

Whole Grain and High Fiber - Global Market Outlook ( )

Whole Grain and High Fiber - Global Market Outlook ( ) Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Whole Grain and High Fiber - Global Market Outlook (2015-2022) Whole Grain and High Fiber - Global Market Outlook

More information

Report and Action Plan

Report and Action Plan PID Awareness Campaign Workshop 17 May 2013, São Paulo, Brazil Report and Action Plan I. Introduction On Friday 17 May 2013, a workshop was organised by (International Patient Organisation for Primary

More information

Cervical Cancer Control in Latin America and the Caribbean ROUNDTABLE POLICY BRIEF. Dr Rolando Camacho Rodríguez

Cervical Cancer Control in Latin America and the Caribbean ROUNDTABLE POLICY BRIEF. Dr Rolando Camacho Rodríguez Cervical Cancer Control in Latin America and the Caribbean ROUNDTABLE POLICY BRIEF Dr Rolando Camacho Rodríguez ABBREVIATIONS CIN DIRAC HPV IAEA IARC LAC LEEP LMIC MoH NCCP NCI NGO PAHO RINC TEC VIA VIL

More information

BRIDGE. Fact Sheet. BRIDGE Survey. The Global Burden of Breast Cancer. Bridging Gaps, Expanding Outreach Metastatic Breast Cancer Patient Survey

BRIDGE. Fact Sheet. BRIDGE Survey. The Global Burden of Breast Cancer. Bridging Gaps, Expanding Outreach Metastatic Breast Cancer Patient Survey Bridging Gaps, Expanding Outreach Metastatic Breast Cancer Patient Survey Fact Sheet BRIDGE There are an estimated 1.3 million new cases of breast cancer each year. 1 Breast cancer is the leading cause

More information

CR and CC contributed equally. Received 30 March 2016 Revised 18 April 2016 Accepted 9 May For numbered affiliations see end of article.

CR and CC contributed equally. Received 30 March 2016 Revised 18 April 2016 Accepted 9 May For numbered affiliations see end of article. Review Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015 Christian Rolfo, 1 Christian Caglevic,

More information

Zika virus (ZIKV) Latin America & Caribbean Situation Report #11 15 February 2017

Zika virus (ZIKV) Latin America & Caribbean Situation Report #11 15 February 2017 UNICEF/Ecuador/2016 Zika virus (ZIKV) Latin America & Caribbean Situation Report #11 15 February 2017 UNICEF/LACRO RESPONSE HIGHLIGHTS UNICEF has worked with government and non-government partners to ensure

More information

FORO: Enhancing Radiation Protection and Nuclear Safety in Ibero-America

FORO: Enhancing Radiation Protection and Nuclear Safety in Ibero-America FORO: Enhancing Radiation Protection and Nuclear Safety in Ibero-America IAEA s Conference on Challenges Faced By Technical and Scientific Support Organizations (TSOs) in Enhancing Nuclear Safety and Security

More information

ARTICLE TITLE / CHAPTER 00. Executive Summary. Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen, Denmark, October 2017

ARTICLE TITLE / CHAPTER 00. Executive Summary. Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen, Denmark, October 2017 ARTICLE TITLE / CHAPTER 00 Executive Summary Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen, Denmark, October 2017 1 / WORLD PSORIASIS HAPPINESS REPORT 2017 LEO Innovation

More information

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures Q4 2009 Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures and Unit Prices Executive Summary The WHO, in collaboration with IMS, has put in place a programme

More information

Cancer in Korea: Present features

Cancer in Korea: Present features Symposium Current Management of Malignant Diseases in the Asian and Oceania Regions [Korea] Cancer in Korea: Present features Hyun-Young SHIN* 1 Cancer has been the leading cause of death in Korea since

More information

Expanding access to injectable contraceptives

Expanding access to injectable contraceptives Expanding access to injectable contraceptives Background Catherine d'arcangues World Health Organization Geneva, 15 June 2009 06_PVL_TURIN_APRIL1 Contraceptive prevalence by method: world and development

More information

RELAF SEMINAR 2010 Nenita La Rose Executive Director CHI

RELAF SEMINAR 2010 Nenita La Rose Executive Director CHI Working with Relaf in The Americas and The Caribbean: child helplines and their role promoting children s rights RELAF SEMINAR 2010 Nenita La Rose Executive Director CHI Magdalena Aguilar Programme Manager

More information

Innovation in accessibility. How UniEvangélica promoted the inclusion of 22 employees who are deaf or hard of hearing within its hearing community

Innovation in accessibility. How UniEvangélica promoted the inclusion of 22 employees who are deaf or hard of hearing within its hearing community Innovation in accessibility How UniEvangélica promoted the inclusion of 22 employees who are deaf or hard of hearing within its hearing community Overview UniEvangélica is a higher-education institution

More information

The Global Alliance for Improved Nutrition

The Global Alliance for Improved Nutrition The Global Alliance for Improved Nutrition JCIE Seminar on Challenges in Global Health: New Opportunities for the Private Sector 27 July 2010, Tokyo 1 Outline Why Nutrition Matters About GAIN GAIN Nutrition

More information

Biodosimetry: Latin American Biological Dosimetry Network (LBDNet)

Biodosimetry: Latin American Biological Dosimetry Network (LBDNet) Biodosimetry: Latin American Biological Dosimetry Network (LBDNet) 23rd WiN Global Annual Conference- Women in Nuclear Meet Atomos for Peace Lic. Marina Di Giorgio mdigiorgio@arn.gob.ar 24 28 August 2015

More information

Economics of Tobacco in Argentina

Economics of Tobacco in Argentina Economics of Tobacco in Argentina Consumption and Prevalence?? In 1999, Argentina was the third largest cigarette consumption country in the Latin America & Caribbean region (LAC), accounted for 15% of

More information

The future of cancer prevention: setting realistic goals and timeframe

The future of cancer prevention: setting realistic goals and timeframe The future of cancer prevention: setting realistic goals and timeframe Dr Christopher P Wild PhD International Agency for Research on Cancer Lyon, France We cannot treat our way out of the cancer problem

More information

REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN

REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN 525 Twenty-third Street, N.W. Washington, D.C. 20037 1 2 In response to the high incidence

More information

Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America

Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America Monaldi Arch Chest Dis 2009; 71: 3, 96-105 ORIGINAL ARTICLE Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America F.J. de Serres

More information

Safety of the Blood Supply in Latin America

Safety of the Blood Supply in Latin America CLINICAL MICROBIOLOGY REVIEWS, Jan. 2005, p. 12 29 Vol. 18, No. 1 0893-8512/05/$08.00 0 doi:10.1128/cmr.18.1.12 29.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Safety of

More information

The epidemiology of tuberculosis

The epidemiology of tuberculosis The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications

More information

Nintedanib in Oncology Backgrounder

Nintedanib in Oncology Backgrounder For media outside the US, UK and Canada only Nintedanib in Oncology Backgrounder 1. What is nintedanib? 2. How does nintedanib work? 3. Data overview 4. Additional clinical data 5. Nintedanib approval

More information

EU5 Bariatric Surgery Procedures Outlook to 2020

EU5 Bariatric Surgery Procedures Outlook to 2020 EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

Haifa. Food Phosphates. Meat, Poultry and Seafood Processing

Haifa. Food Phosphates. Meat, Poultry and Seafood Processing Haifa Food Phosphates Meat, Poultry and Seafood Processing Phosphates for Meat & Poultry Products Phosphates for Dry Addition The quality of sausages, meatballs, hamburgers, chicken nuggets, and other

More information

WORLD RADIOLOGY DAY 2013

WORLD RADIOLOGY DAY 2013 WORLD RADIOLOGY DAY 2013 RADIOLOGY: FACING SOME MAJOR PUBLIC HEALTH CHALLENGES IN LAC: CANCER, CVDS, TB, MATERNAL AND INFANT MORTALITY November 8, 2013. Washington DC. USA Branka Legetic, Unit Chief a.i.,

More information

National, regional, and global trends in metabolic risk factors. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group

National, regional, and global trends in metabolic risk factors. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group National, regional, and global trends in metabolic risk factors Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group Citations Danaei G,* Finucane MM,* Lin JK,* Singh GM,* Paciorek

More information

9 th World. Nephrology Conference. Sao Paulo, Brazil August 15-17, Theme: Latest advancements and new-fangled techniques in Nephrology

9 th World. Nephrology Conference. Sao Paulo, Brazil August 15-17, Theme: Latest advancements and new-fangled techniques in Nephrology Brochure 9 th World Nephrology Conference Sao Paulo, Brazil August 15-17, 2016 Theme: Latest advancements and new-fangled techniques in Nephrology Conference Secretariat 2360 Corporate Circle, Suite 400

More information

Launch of the INCB Annual Reports 2015

Launch of the INCB Annual Reports 2015 Launch of the INCB Annual Reports 2015 Werner Sipp, INCB President 2 March 2016 1 The 3 Reports 2 Mandate of INCB Promote and monitor compliance with the 3 international drug control conventions by: Annual

More information

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB

More information

DEMENTIA IN THE AMERICAS. CURRENT AND FUTURE COST AND PREVALENCE OF ALZHEIMER S DISEASE AND OTHER DEMENTIAs. bupa.com/dementia alz.co.

DEMENTIA IN THE AMERICAS. CURRENT AND FUTURE COST AND PREVALENCE OF ALZHEIMER S DISEASE AND OTHER DEMENTIAs. bupa.com/dementia alz.co. DEMENTIA IN THE AMERICAS CURRENT AND FUTURE COST AND PREVALENCE OF ALZHEIMER S DISEASE AND OTHER DEMENTIAs bupa.com/dementia alz.co.uk CONTENTS FOREWORD 3 about dementia 4 dementia in the americas 8 ABOUT

More information

Page 1 of 6. Hepatitis B Virus (HBV) PRESENTATION RECOMMENDED IMMMUNOSUPRESSIVE TREATMENT TEST RESULTS. Obtain baseline HBV DNA level

Page 1 of 6. Hepatitis B Virus (HBV) PRESENTATION RECOMMENDED IMMMUNOSUPRESSIVE TREATMENT TEST RESULTS. Obtain baseline HBV DNA level Hepatitis B Virus (HBV) PRESENTATION Medical history: Previous history of HBV On anti-hbv medications Hepatitis Screening and Management HBV and HCV Risk factors associated with HBV infection: Born in

More information